CT-202: a Dual pH-dependent Nectin-4xCD3 Bispecific T Cell Engager

Publications

Nov 7

Written By Martin Lehr

Nectin

Martin Lehr

A Phase 1, First-in-Human Study of CTIM-76, a Claudin-6 (CLDN6)-Directed Bispecific Antibody, in Patients with Recurrent Ovarian Cancer and Other Advanced Solid Tumors